ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1877

Trends in Rheumatoid Arthritis Incidence, Prevalence, DALY and Death Rates (1991-2021) in the United States: A Comprehensive Analysis of State-Level Disparities

Aviraag Vijaya Prakash1, Vishwas Hosur Ravishankar2, Aishwarya Sudheer1 and Paramarajan Piranavan3, 1Saint Vincent Hospital, Department of Internal Medicine, Worcester, MA, 2St Vincents Hospital, Worcester, MA, 3University of Kentucky, Division of Rheumatology, Lexington, KY

Meeting: ACR Convergence 2024

Keywords: Demographics, Disability, quality of life, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid Arthritis (RA) exhibits varied epidemiological patterns across states in the United States, influencing disability-adjusted life years (DALYs), incidence rates, prevalence, and mortality. This study aims to analyze the incidence, prevalence, death, and DALY trends in RA from 1991 to 2021 at a state level in the United States.

Methods: The Global Burden of Disease database was used to extract age-standardized incidence, prevalence, death, and disability-adjusted life years (DALYs) of Rheumatoid Arthritis from 1991 to 2021 for both males and females across all states of the U.S. We then calculated the percent change in the rates between 1990 and 2021.

Results: The incidence, prevalence, DALYs, and death related to RA in the United States increased by 42.86%, 48.29%, 31.51%, and 1.36% respectively between 1991 and 2021. Analyzing data from multiple states reveals significant disparities in RA burden (Figure 1). States like Alaska and Maine record higher DALYs, exceeding 90, indicating substantial disability attributed to RA. Conversely, states such as Florida and North Dakota report lower DALYs, suggesting a relatively lower disability impact. Incidence rates highlight Arizona and Hawaii with rates exceeding 50 cases per 100,000 population annually, contrasting with lower incidence in states like Alabama and Arkansas. Prevalence rates demonstrate a similar distribution, with higher rates observed in states such as Vermont and Minnesota. Mortality rates related to RA vary across states, with Alaska and Idaho showing elevated rates, while Delaware and Vermont exhibit lower mortality impacts.

Conclusion: The rising incidence and disparity in rheumatoid arthritis among different states over time may be influenced by several factors, including increased and early recognition and treatment of the disease, genetic and environmental predispositions (such as smoking and pollution), greater use of immunosuppressive medications, variations in healthcare access, socioeconomic status, social habits, and public health policies. These results highlight the need for targeted interventions to mitigate the increasing disease burden of rheumatoid arthritis. Future studies are needed to identify the factors contributing to the disparity.

Supporting image 1

Figure 1. Heat maps exhibiting the difference in the incidence, prevalence, DALY and deaths across the United States


Disclosures: A. Vijaya Prakash: None; V. Hosur Ravishankar: None; A. Sudheer: None; P. Piranavan: None.

To cite this abstract in AMA style:

Vijaya Prakash A, Hosur Ravishankar V, Sudheer A, Piranavan P. Trends in Rheumatoid Arthritis Incidence, Prevalence, DALY and Death Rates (1991-2021) in the United States: A Comprehensive Analysis of State-Level Disparities [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/trends-in-rheumatoid-arthritis-incidence-prevalence-daly-and-death-rates-1991-2021-in-the-united-states-a-comprehensive-analysis-of-state-level-disparities/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-in-rheumatoid-arthritis-incidence-prevalence-daly-and-death-rates-1991-2021-in-the-united-states-a-comprehensive-analysis-of-state-level-disparities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology